about
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLong-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors.Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?n-3 fatty acids in patients with multiple cardiovascular risk factors.Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome.Effectiveness of a nurse-managed protocol to prevent hypoglycemia in hospitalized patients with diabetes.Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification.Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.A polypill strategy to improve adherence: results from the FOCUS project.Emergency department visits in older people: pattern of use, contributing factors, geographical differences and outcomes.Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012.Risk of dementia and death in patients with atrial fibrillation: A competing risk analysis of a population-based cohort.Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.Epidemiologic Trends in Hospitalized Ischemic Stroke from 2002 to 2010: Results from a Large Italian Population-Based Study.Comparison of Health Care Resource Utilization by Immigrants Versus Native Elderly People.Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma.Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators.People's perception of their overall coronary risk: an Italian experience.Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: a large population-based study.Hyperglycemia during acute coronary syndrome: a nurse-managed insulin infusion protocol for stricter and safer control.Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database.Prevalence and management of diabetes in immigrants resident in the Lombardy Region: the importance of ethnicity and duration of stay.The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.Diabetes mellitus: a risk factor for seizures in the elderly-a population-based study.Improving cardiovascular prevention in general practice: Results of a comprehensive personalized strategy in subjects at high risk.Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units.Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study.Response to " Dementia and death: Separate sides of the same Atrial Fibrillation coin?"Moderate anticoagulation by salicylate prevents thrombosis without bleeding complicationsSeveral murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristicsLack of interaction of heparin with ADP and prostacyclin on rat plateletsStroke in two young siblings with congenital dysfibrinogenemiaIncreased PGI2 activity in venous tissues from rats on oral contraceptives is not prevented by heparin administration before vessel isolationOral contraceptives and the prothrombin timePlasmatic and vascular factors of the hemostatic system in rats receiving an estrogen-progestogen combinationA peculiar haemostatic mechanism in the rat?In vitro effect of suloctidil on 14C-5-hydroxytryptamine uptake and liberation in rat plateletsVon Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarctionEarly coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction
P50
Q24645391-7EC063E6-2C91-430E-B08B-7E4464C2183EQ24794281-8E4F5F53-D91C-4ADB-8A9A-2B73E581D4C0Q28183982-9AF8C949-53A2-4D4A-8055-3FD5282D7036Q34651597-9BF70518-F3ED-49AA-AC70-23749181CB62Q35060228-468FF0AE-6C46-4E4A-91AB-05F0E44AD952Q35556845-2202A230-FA17-4938-B692-963886392776Q36893032-EA4C1DC6-9D65-4D1C-A8BE-146CF2668AAFQ37996239-236A3967-DD91-4FD2-A227-BF603058B6C2Q38934203-A1D01C2E-6CED-453C-B877-8DD6DEC27F49Q39956455-9DBC260C-E3E4-4981-806C-7174BA8024A2Q40428524-9E337D99-865B-4A14-89D8-CC8C9A17C079Q40660063-770B7F25-4C47-45D8-8135-C49D65068708Q40685029-6B603EAD-60C6-4E71-8112-91BAC1397114Q40789268-A05A6E83-9368-4DFC-8021-2EEC54FAA7ACQ40861171-21FF2480-CC39-448B-BEA5-54B23BDE157EQ41598657-9D7F12BA-39D8-4E9A-9801-96C3B47A80BEQ42491490-B2121BAB-91E5-4A42-95CD-FDD1A932D7E2Q43521148-7DA89779-452F-4106-A34D-AC5AF84AC57EQ44840969-6D9BF599-A176-4060-A1D8-36A4F47F5551Q45253574-3353D5C2-1251-4550-9E73-8626EBE90430Q46140887-A3BA51C7-92DF-4057-857C-A4CD30E10EF8Q46714741-11711416-FE8D-4463-914C-6A6E804E1365Q48194109-F0E72DF2-078D-4639-82AE-C57B68994AB7Q50507565-842E8106-857E-42A9-AC13-098763F5C4B6Q50576874-05FE039B-6420-4245-9B0F-475C4DC92C6EQ50917252-8F545538-BCAC-4BF2-80A7-1A2641002B7DQ53300768-05103BC4-476B-4DA1-A629-299CAB724E4BQ53911336-2185168B-41E2-4E79-851C-A95DA35F90A7Q54097670-D0CA43C2-3BA8-4876-ACFA-B2CB2460B0C0Q58412113-1FCEF268-E58F-4DF3-BBF1-B97973D22F46Q59697415-C7AED430-EE55-490D-9018-36011D0D8B7FQ59697629-984716C8-570D-4A32-8604-B365DF1A9BB0Q59697652-6057323C-F1A3-437F-A109-6B07CFEBDDCCQ59697852-656D338B-2EFA-451D-B2D6-0388F0D4A4D6Q59697880-AE697B9C-03B5-425A-A1A2-A8D3E8B8AABEQ59697904-40E2AC0B-AFCB-432F-A168-B12EB8C06368Q59698220-AFB3517E-2423-4B1F-B5D3-6BAE36C8D58EQ67579712-15AAEEB6-FA1C-4CBB-A5A4-7C4DF320D2B1Q67816268-750D9BF3-A62B-42DF-A041-8D0E3D70EDE9Q68368837-88C4D847-70E8-4133-A854-AB9BC02A3ED0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Carla Roncaglioni
@ast
Maria Carla Roncaglioni
@en
Maria Carla Roncaglioni
@es
Maria Carla Roncaglioni
@nl
type
label
Maria Carla Roncaglioni
@ast
Maria Carla Roncaglioni
@en
Maria Carla Roncaglioni
@es
Maria Carla Roncaglioni
@nl
prefLabel
Maria Carla Roncaglioni
@ast
Maria Carla Roncaglioni
@en
Maria Carla Roncaglioni
@es
Maria Carla Roncaglioni
@nl
P106
P1153
57190080133
P21
P31
P496
0000-0002-2029-7847